DarioHealth Company
DarioHealth is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.
Industry:
P4 Medicine
Headquarters:
New York, New York, United States
Zip:
101-250
Founded Date:
2011-01-01
Employees Number:
101-250
Funding Status:
IPO
Acquisitions Number:
10
Investors Number:
219003822
Total Funding:
$1M to $10M
Estimated Revenue:
2013-04-09
Last Funding Date:
Post-IPO Debt
Last Funding Type:
info@mydario.com
Register and Claim Ownership